Delivery Order SPE2DB22D3010-SPE2DB25FP3EH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Varivax vaccine with diluents, valued at $78,469.90 with a firm fixed price structure. The contract is set to complete by September 24, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,846.51 for Varivax vaccine with diluents on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-competitive delivery order with performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA, leveraging the company's extensive capabilities as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Varivax vaccine with diluents, with a contract ceiling value of $268,348.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The work is scheduled for completion by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $1,052.96. This is a firm fixed-price delivery order with an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive order placed under an existing contract vehicle, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Varivax vaccine with diluents, valued at $5,782.77. This firm fixed price delivery order, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation, with performance occurring at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Varivax vaccine with diluents, valued at $2,106.02 with a completion date of September 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Varivax vaccine with diluents, valued at $21,060.20. This competitively awarded, firm fixed-price delivery order is set to be completed by October 3, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Varivax vaccine with diluents, valued at $2,106.02. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by July 11, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $94,770.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varivax vaccine with diluents. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varivax vaccine with diluents, valued at $5,212.80. This firm fixed-price delivery order, which must be completed by August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. The award was not...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3EHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Varivax vaccine with diluents, valued at $3,158.88. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents a child contract under AmerisourceBergen's larger federal contract vehicle. The award was made through open competition with no set-aside designation, and performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen serves as a critical supplier to the Defense Health Agency and other federal healthcare systems, providing a broad range of pharmaceutical products and medical supplies in support of military healthcare operations. The Varivax vaccine order represents a routine fulfillment of the company's role as a primary pharmaceutical distributor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/12/25 |